Pharmaceutical investment enterprise professional investment "is unique"

In 2010, the pharmaceutical system and policies were continuously regulated. However, the overall characteristics of the pharmaceutical investment industry show the following characteristics: The pharmaceutical industry is ultimately a very professional industry. This is determined by the nature of the industry. Since the nature of the industry emphasizes professionalism, practitioners in the industry also need to have fairly complete professional knowledge. Industry companies must also have a very professional organization and operation system. Only in this way can medicines match industry characteristics and enhance the competitiveness of enterprises and the level of industry development. As a pharmaceutical investment company, under the traditional telemarketing model, there are no detailed requirements for the investment personnel to start from the drug research to the pharmaceutical industry.

In the eyes of pharmaceutical investment companies, as long as they have strong communication skills and relationship building levels, they can do business and expand their business. Of course, it is undeniable that such a business idea has indeed achieved very good results in the early stages of investment promotion in medicine, and it has created a large number of successful companies and successful individuals. However, along with the return of the nature of the industry, and the public and agents’ attention to information on drug safety, high-end talents who are familiar with the characteristics of drugs, detailed and comprehensive market research, and precise industrial grasp have gradually gained industry recognition.

The so-called refinement of pharmaceutical investment refers to the establishment of a company’s unique advantages in certain aspects based on its own positioning and industry development trends. Through the targeted implementation of investment promotion and market operations, such advantages are maximized. An investment promotion model that continuously enhances the accuracy of pharmaceutical investment promotion and business results.

It is worth noting that there has been a group of companies with strong forward-looking enterprises in the field of investment promotion for medicine that have made precise positioning for themselves, and along this position, they have determined the business planning of pharmaceutical investment enterprises in a certain market segment and adopted drugs. Trade, media and other forms of implementation of brand differentiation and dissemination.

Faced with such a fact, it is imperative to create a good platform that can be effectively and effectively compatible with upstream production companies and downstream agents. This platform is the brand influence of pharmaceutical investment companies. Through a very good pharmaceutical market segmentation, in conjunction with professional organization and operation, and media promotion, we will gradually establish a company’s leading position in a certain market, and build brand influence in this segmentation channel or subdivided product line. . The enterprise is very professional in a certain field, and the manufacturers have targeted varieties to the company to operate successfully, which greatly reduces the many uncertainties of the production companies themselves; at the same time, if the pharmaceutical investment agents have products in the field Intention, directly looking for the cooperation of the pharmaceutical investment enterprise can completely achieve the goal, eliminating many intermediate links, simple and efficient.